Category: Drugstores

Walgreens Says It Won’t Offer the Abortion Pill Mifepristone in Conservative States

The New York Times – Business:
The decision applies to 21 states whose attorneys general threatened Walgreens and other pharmacies with legal action if they dispensed the pill there.
Narcan Is Safe to Sell Over the Counter, Advisers to the FDA Conclude

The New York Times – Business:
The overdose reversal drug has been administered mostly by emergency responders and outreach workers. If the agency approves a nonprescription version, it could become as easily available as aspirin.
CVS and Walgreens Plan to Offer Abortion Pills Where Abortion Is Legal

The New York Times – Business:
The two chains said they would begin the certification process under a new F.D.A. regulation that will allow retail pharmacies to dispense the prescription pills for the first time.
Abortion Pills Can Now Be Offered at Retail Pharmacies, F.D.A. Says

The New York Times – Business:
Mifepristone, the first of two drugs in medication abortions, previously had to be dispensed only by clinics, doctors or a few mail-order pharmacies. Now, if local drugstores or chains like CVS agree to certain rules, they can provide it.
China’s Abrupt Covid Pivot Leaves Many Without Medicines

The New York Times – Business:
Millions are desperate to get their hands on fever-reducing drugs and antivirals such as Pfizer’s Paxlovid as infections across China outpace supplies.
Walmart Agrees to Pay $3.1 Billion to Settle Opioid Lawsuits Nationwide

The New York Times – Business:
The money would help pay for addiction treatment and drug education programs in communities across the United States.
CVS and Walgreens Near $10 Billion Deal to Settle Opioid Cases

The New York Times – Business:
The agreement would resolve thousands of lawsuits over the retailers’ role in the addiction crisis. But a large majority of state, local and tribal governments must sign on for it to take effect.
F.D.A. Confirms Widespread Shortages of Adderall

The New York Times – Business:
The agency cited Teva’s continuing supply problems as well as those of other drug makers struggling to fill the gap.